Andreas Strüngmann

Andreas Strüngmann (born 1950) was born in Germany and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer.[1] In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion,[2] making Sandoz the largest generic-drug company in the world.

He currently has residences in Tegernsee, Germany, Europe and Russia and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis.

See also

References

  1. ↑ Timmons, Heather & Wright, Tom. "Novartis to Buy Two Makers of Generics". New York Times, 22 February 2005. Retrieved on 27 May 2013.
  2. ↑ Forbes. "Andreas Strungmann - Forbes". March 2013. Retrieved on 27 May 2013.

External links


This article is issued from Wikipedia - version of the 10/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.